Stocks
Halozyme (HALO) EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | 259.0 | 315.5 | 451.9 | 656.5 | 904.3 | 960.6 | ||
| Changes by years, y/y, % | +69% | +22% | +43% | +45% | +38% | +42.7% | |||
Halozyme. EBITDA US GAAP, bln rub
Halozyme. EBITDA US GAAP, changes, %
Halozyme. EBITDA US GAAP, sum by quarters, bln rub
Halozyme (HALO) EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | 162.0 | 222.9 | 238.4 | 281.1 | 218.3 | 960.6 | |
| Changes by years, y/y, % | +40% | +62% | +25% | +38% | +35% | |||
| Changes by quarters, q/q, % | -20% | +38% | +7% | +18% | -22% | |||
